{"id":"W4401410496","doi":"10.1159/000540290","title":"Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma","year":2024,"lang":"en","type":"article","venue":"Liver Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sudbury Regional Hospital","funders":"National Cancer Institute; University of California, San Francisco; University of Texas MD Anderson Cancer Center; Puma Biotechnology; Memorial Sloan-Kettering Cancer Center","keywords":"Neratinib; Medicine; Sunitinib; Everolimus; Axitinib; Tyrosine-kinase inhibitor; Nivolumab; Pembrolizumab; Internal medicine; Clinical endpoint; Oncology; Cancer; Immunotherapy; Clinical trial; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008198872,0.0005534685,0.001468007,0.0002761874,0.0002688127,0.0005686372,0.0004774575,0.0004764594,0.001056355],"category_scores_gemma":[0.0007304671,0.0002570648,0.0008232017,0.0004051883,0.0002865398,0.000636126,0.000213311,0.0008414104,0.0002341838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001072562,"about_ca_system_score_gemma":0.0008777764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001120505,"about_ca_topic_score_gemma":0.005187131,"domain_scores_codex":[0.9997821,0.00006856822,0.00002962986,0.00004147941,0.00003199093,0.00004617725],"domain_scores_gemma":[0.9997303,0.00006101322,0.00006239153,0.00001885548,0.00002045018,0.0001068258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.4186746,0.01229785,0.0921144,0.001687802,0.00309919,0.003047343,0.0005330373,0.00922303,0.1050273,0.0004516794,0.007970397,0.3458733],"study_design_scores_gemma":[0.1899485,0.4352432,0.2917655,0.0002941832,0.004980878,0.006810992,0.0006243748,0.01208172,0.03680663,0.0005476847,0.02066749,0.0002288024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933675,0.003989021,0.0001317286,0.0003089451,0.0000563776,0.0001483441,0.0002260948,0.00003352798,0.001738435],"genre_scores_gemma":[0.9976828,0.0009965658,0.0002044248,0.0002411487,0.00004325281,0.00007646945,0.0003866033,0.000005446645,0.0003632726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001468007,"threshold_uncertainty_score":0.007781982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007036782436839323,"score_gpt":0.2275670107357827,"score_spread":0.2205302282989434,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}